Cargando…

Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours

Ovarian carcinomas exhibit extensive heterogeneity, and their etiology remains unknown. Histological and genetic evidence has led to the proposal that low grade ovarian serous carcinomas (LGOSC) have a different etiology than high grade carcinomas (HGOSC), arising from serous tumours of low malignan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birch, Ashley H., Arcand, Suzanna L., Oros, Kathleen K., Rahimi, Kurosh, Watters, A. Kevin, Provencher, Diane, Greenwood, Celia M., Mes-Masson, Anne-Marie, Tonin, Patricia N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232202/ https://www.ncbi.nlm.nih.gov/pubmed/22163003 http://dx.doi.org/10.1371/journal.pone.0028250

Ejemplares similares

The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome
por: Wojnarowicz, Paulina M., et al.
Publicado: (2012)

Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease
por: Fleury, Hubert, et al.
Publicado: (2015)

Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome
por: Gambaro, Karen, et al.
Publicado: (2015)

Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors
por: Ouellet, Véronique, et al.
Publicado: (2008)

A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis
por: Communal, Laudine, et al.
Publicado: (2021)

Characterization of three new serous epithelial ovarian cancer cell lines
por: Ouellet, Véronique, et al.
Publicado: (2008)

RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer
por: Cáceres-Gorriti, Katia Y., et al.
Publicado: (2014)

Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
por: Cavallone, Luca, et al.
Publicado: (2008)

Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families
por: Oros, Kathleen K, et al.
Publicado: (2006)

Germline TP53 mutational spectrum in French Canadians with breast cancer
por: Arcand, Suzanna L, et al.
Publicado: (2015)

A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
por: Belanger, Moria H, et al.
Publicado: (2015)

Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer
por: Létourneau, Isabelle J, et al.
Publicado: (2012)

Cumulative defects in DNA repair pathways drive the PARP inhibitor response in high-grade serous epithelial ovarian cancer cell lines
por: Fleury, Hubert, et al.
Publicado: (2016)

The chemiluminescence based Ziplex(® )automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip(® )expression profiles
por: Quinn, Michael CJ, et al.
Publicado: (2009)

Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis
por: Tsofack, Serges P, et al.
Publicado: (2013)

The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population
por: Alenezi, Wejdan M., et al.
Publicado: (2022)

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
por: Le Page, Cécile, et al.
Publicado: (2019)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
por: Cheasley, Dane, et al.
Publicado: (2022)

High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer
por: Bareche, Yacine, et al.
Publicado: (2021)

An essential role for Ran GTPase in epithelial ovarian cancer cell survival
por: Barrès, Véronique, et al.
Publicado: (2010)

The Continuum of Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary
por: Wong, Kwong-Kwok, et al.
Publicado: (2007)

Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer
por: Sauriol, Alexandre, et al.
Publicado: (2023)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines
por: Cody, Neal AL, et al.
Publicado: (2008)

Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
por: Amuzu, Setor, et al.
Publicado: (2021)

Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma
por: Jena, Saubhagya Kumar, et al.
Publicado: (2015)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer
por: Koti, M, et al.
Publicado: (2015)

BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis
por: Le Page, Cécile, et al.
Publicado: (2012)

A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene
por: Fierheller, Caitlin T., et al.
Publicado: (2021)

CT features of low grade serous carcinoma of the ovary
por: Pannu, Harpreet K.
Publicado: (2015)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

Low-Grade Serous Carcinoma of the Ovary: The Current Status
por: Babaier, Abdulaziz, et al.
Publicado: (2022)

Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent
por: Tischkowitz, Marc, et al.
Publicado: (2013)

Ran GTPase: A Key Player in Tumor Progression and Metastasis
por: Boudhraa, Zied, et al.
Publicado: (2020)

Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease
por: Sauriol, Alexandre, et al.
Publicado: (2020)

Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases
por: Alenezi, Wejdan M., et al.
Publicado: (2023)

Developmental Venous Anomaly: Benign or Not Benign
por: AOKI, Rie, et al.
Publicado: (2016)

BMP-2 signaling in ovarian cancer and its association with poor prognosis
por: Le Page, Cécile, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_im8p4ltk4r9qfq2cqa2k3gequ7